Drugs / IPOL
last change Aug 2013 re-read 3 minutes ago

IPOL

Vaccine

Developed for
poliomyelitis
Investigated by
Eastern Virginia Medical School · NanoPass Technologies Ltd

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01686503 Sep 2012 → Aug 2013 poliomyelitis Eastern Virginia Medical School Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IPOL ClinicalTrials.gov intervention name — accepted as the source's own label NCT01686503 ↗
Modality Vaccine “inactivated polio vaccine” NCT01686503 ↗